选择性和非选择性Pim激酶抑制剂在癌症治疗中的潜在应用。 - Suppr

Suppr

超能文献

Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy.

作者信息

Drygin Denis, Haddach Mustapha, Pierre Fabrice, Ryckman David M

机构信息

Cylene Pharmaceuticals, 5820 Nancy Ridge Drive, Suite 200, San Diego, CA 92121, USA.

出版信息

J Med Chem. 2012 Oct 11;55(19):8199-208. doi: 10.1021/jm3009234. Epub 2012 Sep 4.

DOI:10.1021/jm3009234

PMID:22924342

Abstract

摘要

相似文献

Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy.选择性和非选择性Pim激酶抑制剂在癌症治疗中的潜在应用。

J Med Chem. 2012 Oct 11;55(19):8199-208. doi: 10.1021/jm3009234. Epub 2012 Sep 4.

Pim kinase inhibitors: a survey of the patent literature.Pim 激酶抑制剂：专利文献调查。

Expert Opin Ther Pat. 2010 Feb;20(2):193-212. doi: 10.1517/13543770903496442.

Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (review).丝氨酸/苏氨酸激酶Pim-1的调节剂和抑制剂在肿瘤治疗中的应用（综述）

Mol Med Rep. 2014 Jun;9(6):2051-60. doi: 10.3892/mmr.2014.2139. Epub 2014 Apr 11.

7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity.7-(4H-1,2,4-三唑-3-基)苯并[c][2,6]萘啶：一类新型的 Pim 激酶抑制剂，具有很强的细胞抗增殖活性。

Bioorg Med Chem Lett. 2011 Nov 15;21(22):6687-92. doi: 10.1016/j.bmcl.2011.09.059. Epub 2011 Sep 22.

Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update.PIM1 激酶小分子抑制剂专利更新：2009 年 7 月至 2013 年 2 月。

Expert Opin Ther Pat. 2014 Jan;24(1):5-17. doi: 10.1517/13543776.2014.848196. Epub 2013 Oct 17.

The Pim kinases: new targets for drug development.Pim 激酶：药物研发的新靶点。

Curr Drug Targets. 2011 Dec;12(14):2059-66. doi: 10.2174/138945011798829447.

Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells.新型强效 CK2 和 Pim 激酶双重抑制剂，具有抗癌细胞增殖活性。

Bioorg Med Chem Lett. 2012 May 1;22(9):3327-31. doi: 10.1016/j.bmcl.2012.02.099. Epub 2012 Mar 6.

Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal.PIM1激酶在人类癌症中的潜在作用——分子与治疗评估

Eur J Cancer. 2008 Oct;44(15):2144-51. doi: 10.1016/j.ejca.2008.06.044. Epub 2008 Aug 18.

The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms.致癌 PIM 激酶家族通过多种机制调节药物耐药性。

Drug Resist Updat. 2011 Aug-Oct;14(4-5):203-11. doi: 10.1016/j.drup.2011.04.002. Epub 2011 May 20.

Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives.N-10 取代吡咯并[2,3-a]咔唑衍生物的激酶抑制效力和体外抗增殖活性。

Bioorg Med Chem Lett. 2012 Jun 1;22(11):3807-9. doi: 10.1016/j.bmcl.2012.03.098. Epub 2012 Apr 3.

引用本文的文献

Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors.新型3-氰基吡啶衍生物作为PIM-1抑制剂的设计、合成及抗乳腺癌活性评价

Mol Divers. 2025 Jun;29(3):2565-2584. doi: 10.1007/s11030-024-11010-8. Epub 2024 Nov 9.

Molecular insights and inhibitory dynamics of flavonoids in targeting Pim-1 kinase for cancer therapy.黄酮类化合物靶向Pim-1激酶用于癌症治疗的分子见解与抑制动力学

Front Pharmacol. 2024 Oct 7;15:1440958. doi: 10.3389/fphar.2024.1440958. eCollection 2024.

PIM Kinase Inhibitors as Novel Promising Therapeutic Scaffolds in Cancer Therapy.PIM 激酶抑制剂：癌症治疗中新型有前途的治疗支架。

Curr Top Med Chem. 2024;24(28):2489-2508. doi: 10.2174/0115680266321659240906114742.

Combining machine learning and structure-based approaches to develop oncogene PIM kinase inhibitors.结合机器学习和基于结构的方法来开发致癌基因PIM激酶抑制剂。

Front Chem. 2023 Mar 10;11:1137444. doi: 10.3389/fchem.2023.1137444. eCollection 2023.

The Role of PIM Kinases in Pediatric Solid Tumors.PIM激酶在儿童实体瘤中的作用。

Cancers (Basel). 2022 Jul 22;14(15):3565. doi: 10.3390/cancers14153565.

Design, synthesis and biological evaluation of -arylsulfonyl carbazoles as novel anticancer agents.新型抗癌药物——芳基磺酰基咔唑的设计、合成及生物学评价

RSC Adv. 2018 May 10;8(31):17183-17190. doi: 10.1039/c8ra02939c. eCollection 2018 May 9.

Saccharomonosporine A inspiration; synthesis of potent analogues as potential PIM kinase inhibitors.酿酒单孢菌素A的启发；作为潜在PIM激酶抑制剂的强效类似物的合成。

RSC Adv. 2020 Feb 13;10(12):6752-6762. doi: 10.1039/c9ra10216g.

In Vitro and In Vivo Anti-Breast Cancer Activities of Some Newly Synthesized 5-(thiophen-2-yl)thieno-[2,3-d]pyrimidin-4-one Candidates.一些新合成的 5-(噻吩-2-基)噻吩并[2,3-d]嘧啶-4(3H)-酮类候选物的体外和体内抗乳腺癌活性。

Molecules. 2019 Jun 17;24(12):2255. doi: 10.3390/molecules24122255.

Design and Synthesis of Potent and Selective PIM Kinase Inhibitors by Targeting Unique Structure of ATP-Binding Pocket.通过靶向ATP结合口袋的独特结构设计和合成强效且选择性的PIM激酶抑制剂

ACS Med Chem Lett. 2017 Apr 3;8(5):504-509. doi: 10.1021/acsmedchemlett.6b00518. eCollection 2017 May 11.

Synthesis of new pyridothienopyrimidinone derivatives as Pim-1 inhibitors.新型吡啶并噻吩并嘧啶酮衍生物作为Pim-1抑制剂的合成

J Enzyme Inhib Med Chem. 2017 Dec;32(1):457-467. doi: 10.1080/14756366.2016.1261130.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验